Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Page 1
Pharmacologic targeting of the p62 ZZ domain enhances both anti-tumor and bone-anabolic effects of bortezomib in multiple myeloma.
Haematologica. 2024 May 1;109(5):1501-1513. doi: 10.3324/haematol.2023.283787.
Haematologica. 2024.
PMID: 37981834
Free PMC article.
A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma.
Sabol HM, Ashby C, Adhikari M, Anloague A, Kaur J, Khan S, Choudhury SR, Schinke C, Palmieri M, Barnes CL, Ambrogini E, Nookaew I, Delgado-Calle J.
Sabol HM, et al.
Haematologica. 2024 Feb 22. doi: 10.3324/haematol.2023.284443. Online ahead of print.
Haematologica. 2024.
PMID: 38385272
Free article.
Item in Clipboard
Single-cell Transcriptome Analysis Identifies Senescent Osteocytes as Contributors to Bone Destruction in Breast Cancer Metastasis.
Adhikari M, Kaur J, Sabol HM, Anloague A, Khan S, Kurihara N, Diaz-delCastillo M, Andreasen CM, Barnes CL, Stambough JB, Palmieri M, Reyes-Castro O, Ambrogini E, Almeida M, O'Brien CA, Nookaw I, Delgado-Calle J.
Adhikari M, et al.
Res Sq [Preprint]. 2024 Mar 14:rs.3.rs-4047486. doi: 10.21203/rs.3.rs-4047486/v1.
Res Sq. 2024.
PMID: 38558984
Free PMC article.
Preprint.
Item in Clipboard
Cite
Cite